marcus evans Announces Dates for the 9th Annual Pediatric Clinical Trials Conference

PRLog (Press Release) - Jan. 23, 2013 - marcus evans is proud to announce the dates for the highly anticipated 9th Annual Pediatric Clinical Trials Conference, April 24-26, 2013 in Philadelphia, PA. Sixteen industry leading experts will provide insights on designing and conducting effective global trials in pediatric populations with confidence, while overcoming the risk of clinical and operational failure to maximize success.

The 9th Annual Pediatric Clinical Trials Conference is a vital event for those working in Pediatric Clinical Trials, Pediatric Drug Development, Clinical Research and Recruitment and Retention. marcus evans conferences are more intimate conferences, with about 60 senior-level delegates expected to attend this year’s conference.

Attendees can expect an intimate classroom style setting that encourages audience engagement and participation, with 16 interactive presentations and panel discussions and over four hours of networking.

This nationally-recognized conference will focus on the following topics:
•   Navigate the global regulatory framework for pediatric clinical research and drug development      
•   Overcome unique challenges in pediatric clinical trial design
•   Manage multiple site trials while ensuring consistency of study conduct
•   Discover new strategies in pediatric patient recruitment and retention      
•   Explore the issues and challenges unique to different therapeutic areas for pediatric clinical trials
Join our two key speakers at this premiere conference; Sophie Biguenet, Medical Director, Global Clinical Research Virology, Bristol-Myers Squibb and William Treem, Clinical Leader, Established Products at Johnson & Johnson.

Sophie Biguenet is the Medical Director Global Clinical Research of Virology at the Pediatric Center of Excellence. She has been with the Bristol-Myers-Squibb USA Global team since May 2011. Her specialties include clinical development, most specifically with clinical trial phase II, III and IV immunosuppressive drugs and antiviral drugs. Sophie also has a strong background in regulatory and clinical pharmacology activities and medical-marketing activities. Sophie will be speaking on “Managing Multiple Site Trials while Ensuring Consistency of Study Conduct”, which focuses on how to properly run multiple site trials.

Dr. Treem is a board-certified pediatric gastroenterologist and pediatrician who spent the first 28 years of his career as an academic pediatric gastroenterologist and division chief of Pediatric Gastroenterology, Hepatology, and Nutrition at medical schools and University Hospitals in Connecticut, North Carolina, and New York City.  For the last three years, Dr. Treem has functioned as a Research Pharmaceutical Services consultant and Clinical Leader in the Established Products therapeutic area of Janssen Pharmaceutical Research and Development.  He has been involved in pediatric exclusivity programs, new drug development programs, limited access programs, and regulatory filings for a number of gastrointestinal drugs.

For more information, please contact Michele Westergaard, Senior Marketing Manager, 312-540-3000 ext. 6625 or Michelew@marcusevansch.com.